From professional translators, enterprises, web pages and freely available translation repositories.
chr
cba
Last Update: 2014-11-21
Usage Frequency: 1
Quality:
chr:
täielik hematoloogiline vastus:
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
chr rate n (%)
täielik hematoloogiline ravivastus n (%)
Last Update: 2017-04-26
Usage Frequency: 2
Quality:
chrysen (chr)
krüseen (chr)
Last Update: 2014-11-21
Usage Frequency: 3
Quality:
chr (chronic cml):
chr (krooniline cml):
Last Update: 2012-04-11
Usage Frequency: 2
Quality:
chr 92% (86–95)
chr 92% (86...95)
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
complete haematological response (chr)
täielik hematoloogiline ravivastus
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
chr - char to be added into file.
chr - tähemärk, mis lisatakse faili.
Last Update: 2018-02-21
Usage Frequency: 1
Quality:
chr (95% ci) nel (95% ci)
chr (95% ci) nel (95% ci)
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
stemmacantha cynaroides (chr. son. in buch) ditt
stemmacantha cynaroides (chr. son. in buch) ditt
Last Update: 2014-11-21
Usage Frequency: 1
Quality:
percent (%) of patients a haematologic response rate (%) chr
patsiente (%) a
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
failure to achieve complete haematologic response (chr) by week 8
täieliku hematoloogilise ravivastuse (ingl complete haematologic response, chr) saavutamise ebaõnnestumine 8. nädalaks.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
1 114 cp patients had a chr at baseline and were therefore not assessable for complete haematological response
1 114 kf patsiendil esines ravieelselt chr, mistõttu neid ei hinnatud täieliku hematoloogilise ravivastuse suhtes
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
one patient with the e255v mutation previously treated with nilotinib achieved chr as best response.
Üks e255v mutatsiooniga patsient, keda oli varem ravitud nilotiniibiga, saavutas parima vastusena täieliku hematoloogilise vastuse.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
in eleven patients pdgfr gene rearrangements was detected, 9 of them achieved a chr and 1 phr.
Üheteistkümnel patsiendil tuvastati pdgfr geneetiline rekombinatsioon, neist 9 saavutasid täieliku ja 1 osalise hematoloogilise ravivastuse.
Last Update: 2017-04-26
Usage Frequency: 3
Quality:
complete haematological response (chr) in cp patients was evaluated as a secondary endpoint.
teisese tulemusnäitajana hinnati kf patsientidel täielikku hematoloogilist ravivastust (chr).
Last Update: 2017-04-26
Usage Frequency: 3
Quality:
in 22 cp patients evaluated for efficacy tasigna induced a 32% mcyr rate and a 50% chr rate.
22 kf patsiendil, kellel hinnati ravimi efektiivsust, saavutati tasigna’ga mcyr sagedus 32% ja chr sagedus 50%.
Last Update: 2017-04-26
Usage Frequency: 3
Quality:
nel same criteria as for chr but anc ≥ 1 x 109/l and platelets ≥ 20 x 109/l
leukeemia tunnuste puudumine: samad kriteeriumid nagu eespool, kuid neutrofiilide absoluutarv ≥ 1 x 109/l ja trombotsüüte ≥ 20 x 109/l
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
prior complete haematologic response (chr) to imatinib was achieved in 93% of the overall patient population.
eelnev täielik hematoloogiline ravivastus (chr) imatiniibile oli saadud 93%-l kõigist haigetest.
Last Update: 2017-04-26
Usage Frequency: 3
Quality:
three patients presented a complete haematological response (chr) and one patient experienced a partial haematological response (phr).
kolm patsienti saavutasid täieliku hematoloogilise ravivastuse ning üks patsient osalise hematoloogilise ravivastuse.
Last Update: 2017-04-26
Usage Frequency: 3
Quality: